Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020

SELL
$23.3 - $45.96 $901,779 - $1.78 Million
-38,703 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$34.58 - $48.06 $1.03 Million - $1.43 Million
29,697 Added 329.75%
38,703 $1.66 Million
Q2 2019

Aug 06, 2019

SELL
$35.13 - $55.53 $4,918 - $7,774
-140 Reduced 1.53%
9,006 $407,000
Q1 2019

May 13, 2019

BUY
$42.83 - $59.91 $391,723 - $547,936
9,146 New
9,146 $497,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.